Our senior level management team brings decades of experience in the global health care sector, and have come to this industry with a common goal: To improve the treatment options for Canadian patients by advancing the science of medical cannabis.
Mr. Gimelshtein is the CFO of the Company, providing leadership on financial matters, including capital structure, forecasting, budgeting and reporting, as well as corporate development and data-driven business optimization. Previously, he was a Vice-President at Birch Hill Equity Partners, a Canadian mid-market private equity firm. While at Birch Hill, Mr. Gimelshtein worked on the development and management of a number of the portfolio companies and potential investments across a wide range of industries, each of which was aimed at generating significant growth and value-creation.
Mr. Gimelshtein played a key role in Birch Hill’s investments in companies such as Softchoice, Shred-it, DHX Media (formerly Cookie Jar Entertainment), Carmanah Design and Manufacturing, and Mastermind Toys. Prior to joining Birch Hill, Mr. Gimelshtein worked in San Francisco and New York for Union Square Advisors as an investment banker focused on the technology sector. At Union Square he evaluated and executed mergers and acquisitions, and financing transactions across the software, internet and digital media and hardware sectors. Mr. Gimelshtein is an active philanthropist, spending the majority of his volunteer time working with the executive team and board of directors of the Toronto Foundation on various initiatives. Mr. Gimelshtein holds an HBA (Ivey Scholar) from the Richard Ivey School of Business at Western University.
Mr. Latysh is the Vice President, Information Technology of the Company. With over 30 years of experience in information technology across multiple verticals, he provides leadership for the continued development of an innovative, robust and secure information technology environment at MedReleaf.
Prior to joining the Company, Mr. Latysh held a number of senior positions within the marketing and professional services industries. Most recently, he was Director of Technology at Sapient Nitro, a leading technology, marketing and insights consultancy. At Sapient Nitro, Mr. Latysh acted as a delivery lead for e-commerce implementations for some of North America’s most well-known retail brands.
Previously, Mr. Latysh was Principal Software Engineer at Infor and Chief Technology Officer at Refine Data Solutions Inc. This experience has provided Mr. Latysh with a deep understanding of various technical environments, information security and software development methodologies. Throughout his career, Mr. Latysh has also effectively managed and led software development initiatives. Mr. Latysh holds an MA in Electronics Engineering and Computer Programming from Dnepropetrovsk State University, Ukraine.
Christie brings over 15 years of senior financial, accounting and reporting leadership for both public and private companies in a variety of industries, including manufacturing, service delivery, real estate, construction and retail. Prior to joining MedReleaf, Christie was the VP Finance for FirstOnSite Restoration, a national provider of disaster restoration, owned by private equity firm TorQuest (until 2016). At FirstOnSite, Christie championed the centralization of the finance team, generating significant cost savings and business process improvements across the organization, while concurrently realigning finance and reporting objectives with the company’s business strategy. Previously, Christie was the Controller for Brookfield Real Estate Services Inc. and Coretec Inc., both TSX®-listed companies. As a seasoned Controller, leading teams of up to 17 finance professionals, Christie has focused her career in accounting, budgeting and forecasting, business modelling, treasury management, internal controls, public company reporting and compliance. Christie has implemented and led various initiatives, including major ERP system integrations, process re-engineering, internal control assessment and development, IFRS conversions and supporting various business mergers and acquisitions. Christie is a designated CPA, CGA and holds a BA from Athabasca University as well as a diploma in Accounting and Finance from Seneca College.
Mr. Duncan is the Vice President, Engineering of the Company, responsible for infrastructure construction, development and reliability. This includes all physical assets, equipment and systems related to the growth, manufacture and distribution of our products.
Mr. Duncan applies the rigour developed over 20 years designing, constructing and maintaining facilities for Canada’s leading healthcare and pharmaceutical providers. Prior to joining MedReleaf, he was Global Director for Engineering at Apotex, one of Canada’s leading pharmaceutical companies, where he led a team responsible for nearly $100 million in capital work.
As Project/Engineering Manager for significant capital expansions in the pharmaceutical industry, Mr. Duncan has implemented effective systems for workflow processes as well as capital and financial reporting. He represented the prime consultant for the Sunnybrook Health Sciences Centre M/S wing expansions – a $200 million project that was delivered to Infrastructure Ontario standards of cost and scope accountability.
Mr. Duncan also has extensive experience in electrical and control system design for the automotive and pharmaceutical sectors.
Mr. Duncan is a graduate of the University of Waterloo and is a registered professional engineer in Ontario, as well as a licensed electrician.
Ms. Park, Director of Quality Assurance and Compliance, has over 12 years of experience in the design and implementation of quality management systems, with a focus on patient-centred care and risk management. Her expertise includes mergers and acquisitions, as well as the integration of medical laboratory best practices, patient safety and regulatory affairs.
Prior to joining MedReleaf, Ms. Park held leadership roles in community and hospital medical laboratories and accreditation programs. Most recently she was the Manager, Quality & Regulatory Affairs for LifeLabs Ontario, managing a team of professionals and overseeing quality assurance programs across the province.
Ms. Park is certified by the Canadian Society for Medical Laboratory Science (CSMLS) to practise medical laboratory technology within Canada and is in good standing with the College of Medical Laboratory Technologist of Ontario (CMLTO). She is a Certified Quality Improvement Associate through the American Society of Quality and has completed the Laboratory Quality Management Certificate from the Michener Institute in Toronto. A seasoned auditor with the Institute for Quality Management in Healthcare, Ms. Park is a noted writer and speaker on risk management, quality and innovation. She sits on the Standards Council of Canada mirror committee, facilitating Canadian participation in international standardization systems.
Ms. Park holds a bachelor’s degree from the University of Toronto, and a diploma in Medical Laboratory Science from the Michener Institute. She is currently working towards a Master of Health Management from Charles Sturt University.
Katie Maruoka is a seasoned professional with extensive experience in regulatory affairs gained at a variety of pharmaceutical and biotechnology companies. Prior to joining MedReleaf, she was Regulatory Affairs Manager at Apobiologix Inc., where she led pre-clinical/clinical development and global regulatory submissions for biosimilar drug products in oncology, inflammation and general medicine. As Regulatory Affairs Manager at Amgen Canada Inc., she directed Canadian regulatory submissions for innovative biologic and small molecule drug products in several therapeutic areas. She has also held positions in regulatory affairs as well as pharmacovigilance at Viventia Biotech Inc., Apotex Inc. and Draxis Health Inc. Katie earned a Master of Science in Biochemistry at Queen’s University.